GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,780.50p
   
  • Change Today:
    -7.00p
  • 52 Week High: 1,901.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,075.43m
  • Volume: 435,317
  • Market Cap: £72,563m
  • RiskGrade: 129
  • Beta: 0.99

Latest Deals

Traded Action Notifier PriceAmountValue
14-Jan-26 Buy Dividends Hal Barron 1,871.05p 5,664 £105,976.17
08-Jan-26 Buy Dividends Luke Miels 1,894.33p 3 £56.83

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
14-Jan-26 Buy Dividends Hal Barron 1,871.05p 5,664 £105,976.17
08-Jan-26 Buy Dividends Luke Miels 1,894.33p 3 £56.83

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,476,956 £4,513,157,202
Hal Barron 15,321,339 £272,796,441
Jonathan Symonds 71,193 £1,267,591
Charles Bancroft 67,008 £1,193,077
Julie Brown 44,444 £791,325
Anne Beal 7,780 £138,523
Harry (Hal) C. Dietz 6,206 £110,498
Elizabeth (Liz) McKee Anderson 4,679 £83,310
Wendy Becker 3,503 £62,371
Jeannie Lee 3,298 £58,721
Luke Miels 3 £53

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £4,512,928,443
Dodge & Cox 253,464,108 £4,512,928,443
BlackRock Inc 231,975,400 £4,130,321,997
GSK plc 197,068,169 £3,508,798,749
The Capital Group Companies, Inc. 159,068,073 £2,832,207,040
Legal & General Group Plc 95,878,187 £1,707,111,120

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,780.50p
Change Today -7.00p
% Change -0.39 %
52 Week High 1,901.50
52 Week Low 1,264.00
Volume 435,317
Shares Issued 4,075.43m
Market Cap £72,563m
Beta 0.99
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

GSK Key Personnel

CEO Luke Miels

Top of Page